Skip to main content
. Author manuscript; available in PMC: 2014 Jan 14.
Published in final edited form as: Arthritis Rheum. 2013 Nov;65(11):2898–2906. doi: 10.1002/art.38119

Figure 6.

Figure 6

Lack of direct correlation between prednisone use and FoxP3+Helios + Treg cells in patients with systemic lupus erythematosus (SLE). A, Spearman’s rank correlation between the mean daily prednisone dose and clinical disease activity, as determined by Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores. B, Spearman’s rank correlation between the percentage of FoxP3+Helios+ Treg cells and the daily prednisone dosage in SLE patients of all clinical disease activity groups.